Home > Income Statement > CONCORD BIOTECH

CONCORD BIOTECH
Consolidated Net Profit

    Back to Income Statement
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
AD     Remove this Ad

CONCORD BIOTECH Last 5 Year Consolidated Net Profit History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
Consolidated Net Profit ₹308 Cr₹240 Cr₹17 Cr₹235 Cr₹1,690 Cr

What is the latest Consolidated Net Profit of CONCORD BIOTECH ?

The latest Consolidated Net Profit ratio of CONCORD BIOTECH is ₹308 Cr based on Mar2025 Consolidated results.
Year Consolidated Net Profit
Mar2025₹308 Cr
Mar2024₹240 Cr
Mar2023₹17 Cr
Mar2022₹235 Cr
Mar2021₹1,690 Cr

How is Consolidated Net Profit of CONCORD BIOTECH Trending?

Years Consolidated Net Profit % Change
Mar2025 ₹308 Cr
28.33
Mar2024 ₹240 Cr
1,272.47
Mar2023 ₹17 Cr
-92.55
Mar2022 ₹235 Cr
-86.10
Mar2021 ₹1,690 Cr -

Compare Consolidated Net Profit of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹11,520.1 Cr -6.7% -3.8% -30.8% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹418,528.0 Cr -3.1% 1.6% 5.6% Stock Analytics
DIVIS LABORATORIES ₹158,686.0 Cr -1.5% -3.4% 9.3% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,457.0 Cr -4.1% -1.2% 40.3% Stock Analytics
DR REDDYS LABORATORIES ₹106,339.0 Cr -1.5% -0.9% 16.8% Stock Analytics
CIPLA ₹100,056.0 Cr -5.7% -7.8% -13.2% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex

Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

-6.7%

-3.8%

-30.8%

SENSEX

-2.4%

-10.9%

0.2%


You may also like the below Video Courses